Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06932861
Recruiting
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Early phase 1 · China · 1 site
Registry update: 26 Oct 2026
2025-521497-34-00
Recruiting
Long-term follow-up of patients treated with GD2IL18CART
Phase 1 · Germany · 4 sites
Registry update: 23 Sept 2026
NCT07153887
Recruiting
Vebreltinib for Advanced or Metastatic CCS
Phase 2 · China · 1 site
Registry update: 30 Sept 2025
NCT06474676
Recruiting
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Phase 1 · United States · 1 site
Registry update: 3 Nov 2026
NCT06939855
Recruiting
QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Phase 2 · China · 1 site
Registry update: 19 Nov 2025
NCT06441331
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Phase 1 · Spain, France, Italy, United States · 10 sites
Registry update: 27 Oct 2026
NCT06865664
Recruiting
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Phase 1 · United States · 1 site
Registry update: 16 Oct 2026
NCT07124000
Recruiting
DESTINY-PANTUMOUR04
Not applicable · United States · 18 sites
Registry update: 25 Sept 2026
NCT06941194
Recruiting
Preventive Application of Single-use Negative Pressure Wound Therapy (sNPWT) in the Postoperative Course of Radiotreatated Limb Sarcoma Surgery
Not applicable · Italy · 1 site
Registry update: 2 Dec 2025
NCT07049848
Recruiting
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT06528769
Recruiting
Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Phase 2 · United States · 1 site
Registry update: 1 Oct 2026
NCT06503146
Recruiting
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · United States · 1 site
Registry update: 29 Oct 2026
NCT07014137
Recruiting
A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Phase 2 · Canada · 1 site
Registry update: 4 Jun 2026
NCT07215611
Recruiting
Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Not applicable · United States · 1 site
Registry update: 11 Sept 2026
NCT07725783
Recruiting
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
Not applicable · China · 1 site
Registry update: 24 Jul 2026
NCT07134192
Recruiting
Fluorescence-Guided Optimization of Sarcoma Margins
Not applicable · Denmark · 2 sites
Registry update: 1 Jul 2026
NCT06712810
Recruiting
Q702 for the Treatment of Patients With Hematologic Malignancies
Phase 1 · United States · 2 sites
Registry update: 10 Oct 2025
NCT06910657
Recruiting
IDOV-Immune for Advanced Solid Tumors
Phase 1 · Australia, United States · 5 sites
Registry update: 5 Aug 2026
NCT06958107
Recruiting
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
Not applicable · United States · 2 sites
Registry update: 21 Oct 2026
NCT06445166
Recruiting
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Phase 2 · United States · 1 site
Registry update: 6 Apr 2026

Ordered by registry start date. Freshness and sponsorship never change the order.